创新药概念
创新药板块以新分子实体与差异化机制药物研发为核心，覆盖靶向与免疫治疗、ADC、基因与细胞疗法，以及药物发现、临床开发到商业化全链条。板块总市值达 1786.23 billion HKD，24h 涨跌幅 -1.10%，40 个标的中上涨 9 个（占比 22.50%），下跌 30 个（占比 75.00%）。领涨个股为 乐普生物－B (02157)，24h 涨幅 +3.37%。该板块在涨跌参差的走势中回落，尽管龙头股表现更好。保持精选：围绕临床或政策催化事件进行交易；偏好现金充足、处于后期临床阶段的管线，并在走弱时逢低加仓，因为利率和报销信号正在影响估值。
名称 | 最新价 | 涨跌幅 | 最新价 / 涨跌幅 | 走势图 | 价格区间 | 操作 |
|---|---|---|---|---|---|---|
 石药集团01093 | HK$8.44¥7.29 | +1.68%+¥0.12 | HK$8.44 +1.68% | ¥7.16¥7.44 | ||
 信达生物－B01801 | HK$89.25¥77.10 | -0.11%-¥0.08 | HK$89.25 -0.11% | ¥76.24¥77.75 | ||
 金斯瑞生物科技01548 | HK$16.90¥14.60 | +0.47%+¥0.06 | HK$16.90 +0.47% | ¥14.16¥14.60 | ||
 药明康德02359 | HK$156.5¥135.2 | -0.31%-¥0.4 | HK$156.5 -0.31% | ¥134.5¥136.1 | ||
 康诺亚－B02162 | HK$78.20¥67.55 | -4.98%-¥3.54 | HK$78.20 -4.98% | ¥66.82¥71.70 | ||
 百济神州06160 | HK$195.7¥169.0 | -2.00%-¥3.4 | HK$195.7 -2.00% | ¥169.0¥173.1 | ||
 药明生物02269 | HK$38.48¥33.24 | -0.46%-¥0.15 | HK$38.48 -0.46% | ¥33.12¥33.60 | ||
 康方生物09926 | HK$95.35¥82.37 | -3.29%-¥2.80 | HK$95.35 -3.29% | ¥82.15¥85.57 | ||
 晶泰控股02228 | HK$6.87¥5.93 | -4.18%-¥0.25 | HK$6.87 -4.18% | ¥5.91¥6.28 | ||
 三生制药01530 | HK$16.90¥14.60 | -1.34%-¥0.19 | HK$16.90 -1.34% | ¥14.60¥14.81 | ||
 科伦博泰生物－B06990 | HK$503.0¥434.5 | -2.04%-¥9.0 | HK$503.0 -2.04% | ¥431.9¥443.6 | ||
 荣昌生物09995 | HK$84.20¥72.74 | -1.69%-¥1.25 | HK$84.20 -1.69% | ¥71.96¥74.21 | ||
 药明合联02268 | HK$52.65¥45.48 | -3.12%-¥1.46 | HK$52.65 -3.12% | ¥45.48¥47.17 | ||
 中国生物制药01177 | HK$5.04¥4.35 | -0.98%-¥0.04 | HK$5.04 -0.98% | ¥4.34¥4.42 | ||
 翰森制药03692 | HK$32.10¥27.73 | -0.61%-¥0.17 | HK$32.10 -0.61% | ¥27.69¥28.25 | ||
 巨子生物02367 | HK$28.62¥24.72 | -1.44%-¥0.36 | HK$28.62 -1.44% | ¥24.62¥25.64 | ||
 乐普生物－B02157 | HK$4.59¥3.96 | +3.37%+¥0.12 | HK$4.59 +3.37% | ¥3.77¥4.12 | ||
 恒瑞医药01276 | HK$57.15¥49.37 | +0.17%+¥0.08 | HK$57.15 +0.17% | ¥48.98¥49.80 | ||
 康哲药业00867 | HK$11.95¥10.32 | -0.58%-¥0.06 | HK$11.95 -0.58% | ¥10.28¥10.49 | ||
 再鼎医药09688 | HK$14.70¥12.69 | -1.14%-¥0.14 | HK$14.70 -1.14% | ¥12.68¥12.91 |